• Boston Scientific Receives FDA Approval for the Ranger Drug-Coated Balloon americanpharmaceuticalreview
    November 05, 2020
    Boston Scientific has received U.S. Food and Drug Administration (FDA) approval of the Ranger™ Drug-Coated Balloon, developed for the treatment of patients with peripheral artery disease (PAD) in the superficial femoral artery (SFA) and proximal ...
PharmaSources Customer Service